Trials / Completed
CompletedNCT02303483
The Effect of Vitamin B3 on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men
The Effect of Nicotinamide Ribose (NR) on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men - a Randomized, Placebo Controlled Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Aarhus University Hospital · Academic / Other
- Sex
- Male
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
In animals, treatment with vitamin B3 improved insulin sensitivity and substrate metabolism. It is currently not know if vitamin B3 has the same positive effects in humans. In the current study the effect of a 3 month treatment with vitamin B3 on insulin sensitivity and substrate metabolism in obese men will be investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Nicotinamide riboside (NIAGEN TM, ChromaDex, CA, USA ) | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2016-01-04
- Primary completion
- 2017-04-04
- Completion
- 2017-04-04
- First posted
- 2014-12-01
- Last updated
- 2017-07-02
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02303483. Inclusion in this directory is not an endorsement.